Sporadic amyotrophic lateral sclerosis
MONDO:0005145Sporadic amyotrophic lateral sclerosis is a amyotrophic lateral sclerosis in which there is no known cause, such as no family history.
11 clinical trials for this condition and its sub-types, 2 tagged with Sporadic amyotrophic lateral sclerosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New ALS drug safety trial launches for Long-Term study
Disease control Recruiting nowThis study tests the long-term safety of a drug called LY4256984, given via spinal injection, in people with ALS. It includes 32 participants who completed an earlier study and will be followed for about 96 weeks. The main goal is to see how many people have serious side effects …
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New ALS drug injected into spine begins human testing
Disease control Recruiting nowThis early-stage study tests a new drug called LY4256984 in 32 people with sporadic ALS. The drug is injected into the spine to see if it is safe and how the body handles it. The main goal is to check for side effects, not yet to prove it works.
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC